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Mutations of the p53 gene have been implicated as an
important factor in the pathogenesis of ultraviolet light
induced skin cancers. To examine the role of p53 in skin
carcinogenesis, we observed the development of skin
cancers in homozygous p53-deficient (–/–) mice and
wild-type p53 (F/F) mice, after chronic ultraviolet B
(290–320 nm) exposure. At a dose of 2 J per m2 per s of
ultraviolet B for 30 min three times per week, all p53–/–
mice developed skin tumors by week 12. All the p53–/–
mice developed multiple tumors by week 16. The major-
ity of the tumors occurred on the ears. None of the
p53F/F mice developed skin tumors after 17 wk of UV
Squamous cell carcinoma (SCC) is the second most commonskin cancer and is potentially fatal. Its incidence has increasedrapidly world-wide in recent years, especially amongCaucasian populations (Gloster and Brodland, 1996). It iswell established that ultraviolet radiation (UVR) plays an
important role in the pathogenesis of cutaneous SCC (Kelfkens et al,
1990). UVR causes DNA damage in the forms of pyrimidine dimers
and other photoproducts, which in turn can lead to mutations of
critical genes (Alcalay et al, 1990). Once one or more growth regulatory
genes are mutated, malignant transformation will occur.
p53 is an important regulator of cell growth and signal transduction.
It is believed that the key function of this protein is its acting as a
check point in the cell cycle, especially after a DNA-damaging event
(Kastan et al, 1992). Dysfunction of this protein will lead to faulty cell
growth regulation and cancer development. Indeed, the p53 gene has
been found to be the most frequently mutated gene in human cancers
(Hollstein et al, 1991). Mutations of the p53 tumor suppressor gene
have been observed in over 90% of nonmelanoma skin cancers (Brash
et al, 1996), including human cutaneous SCC (Brash et al, 1991; Burns
et al, 1993), UVB-induced mouse SCC (Kress et al, 1992; Kanjilal
et al, 1993), human basal cell carcinomas (Rady et al, 1992), and skin
tumors (both squamous cell and basal cell carcinomas) from DNA-
repair-deficient xeroderma pigmentosum patients (Dumaz et al, 1993).
A majority of these mutations occurred at dipyrimidine sites, character-
ized by C→T transitions or CC→TT base substitutions (Kress et al,
1992; Rady et al, 1992; Dumaz et al, 1993). These are specific UV-
induced mutations and are rarely seen in internal tumors, suggesting
that these mutations are direct results of UVR (Brash et al, 1991).
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exposure. Ten p53–/– tumors were examined histo-
logically: five invasive squamous cell carcinomas, four
squamous cell carcinomas in situ, and one actinic
keratosis. p53–/– mice have a short life-span due to
internal tumors or a deficiency in the immune system;
however, ultraviolet B exposure did not significantly
reduce the life-span of p53–/– mice. These results
demonstrate that loss of wild-type p53 function shortens
the latent period and predisposes the animals to the
development of squamous cell carcinomas after ultra-
violet irradiation. J Invest Dermatol 110:72–75, 1998
To study the role of p53 in the development of skin cancers, we
previously used the p53 transgenic mice that carry both wild-type and
mutant p53 alleles (Laviguer et al, 1989) by observing the development
of skin cancers induced by chronic UVR. We found that the p53
transgenic mice developed more tumors and more multiple tumors
than control mice, but the latent period for skin tumor development
was similar in p53 transgenic and control groups (Li et al, 1995). p53
mutations have been found in actinic keratosis, a precursor lesion of
SCC (McGregor et al, 1992; Sim et al, 1992; Taguchi et al, 1993;
Ziegler et al, 1994), indicating that mutations of the p53 gene occur
at early stages of SCC development. The similar latent period for the
development of SCC in p53 transgenic mice compared with control
mice suggested that the wild-type p53 in the transgenic mice may still
function as a tumor suppressor. To test this hypothesis, we used
the p53-deficient mouse model (Donehower et al, 1992) for skin
photocarcinogenesis experiments. Here we report that mice deficient
in p53 function are prone to skin cancer development with a shortened
latent period after UVR.
MATERIALS AND METHODS
Mice p531/1 and p53–/– mice were purchased from GenPharm
(Mountainview, CA). p53–/– mice carry a disrupted, nonfunctional p53 gene,
which was created by homologous recombination in an embryonic stem cell
line and by microinjection of the stem cells into 3.5-d-old C57BL/6 blastocysts
as described (Donehower et al, 1992). Each mouse was identified with ear tags
and genotyped by Southern blot analysis of tail tip DNA using a BamH1 digest
and p53 probe (Donehower et al, 1992).
Exposure to UV radiation Male mice aged 11–12 wk were divided into
four groups: 14 p531/1 mice exposed to UV, 15 p531/1 mice without UV
exposure, 12 p53–/– mice exposed to UV, and 12 p53–/– mice without UV
exposure. Prior to UV irradiation, hair on the dorsal area of all the mice,
including the control mice that were not exposed to UVR, was shaved using
an Oster electric clipper with a no. 40 blade, and this procedure was performed
before UV irradiation when necessary. For UV irradiation, a bank of four
unfiltered FS40 sunlamps (290–320 nm) (Westinghouse, Bloomfield, NJ) was
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Figure 1. Percentage of animals surviving without tumors (0.3 cm in
diameter) in p53F/F and p53–/– mice. p531/1 (n 5 14) and p53–/– (n 5
12) male mice were shaved in the dorsal area and exposed to 2 J per m2 per s
of UVB (290–320 nm) for 30 min three times per week.
used. The intensity of the UV light was measured by an IL 700 radiometer
fitted with a WN 320 UVB filter (290–320 nm) and an A127 quartz diffuser
(International Light, Newburyport, MA). The mice were exposed to 2 J per
m2 per s for 30 min three times per week (Monday, Wednesday, and Friday).
The mice were housed 4–5 to a cage, and the cage order was systematically
rotated prior to each UV exposure to compensate for any uneven lamp output.
Tumor observation and analysis All animals were examined weekly for
tumor development. The location and size of each tumor were recorded. For
the purpose of this study, a tumor is defined as a visible and palpable nodule
with a minimum diameter of 3 mm and persistence for at least 2 wk. The
Kaplan and Meier (1958) analysis was used to describe the patterns of tumor
development in the carcinogenesis study. This is a life table analysis and thus
takes into account animals that die before developing a tumor. The results are
expressed as the probability that an animal survives free of skin tumor as a
function of the duration of UVR. Differences in tumor incidence between
groups were analyzed by χ2-test.
Histology of tumors Tumors were excised and fixed in 10% formalin.
Tissue was then processed and embedded in paraffin by routine methods. Six-
µm sections were cut and stained with hematoxylin and eosin for light
microscopic examination.
RESULTS
Tumor induction During the photocarcinogenesis experiment, all
the p531/1 control mice survived; one UV-irradiated p531/1 mice
died at age 14 wk without skin tumor development; and nine UV-
irradiated p53–/– mice (six without skin tumors) and eight non-UV-
irradiated p53–/– mice died at age 20.7 6 4.3 and 24.1 6 5.7 wk,
respectively. Skin tumors started to appear in p53–/– mice after 11 wk
of UV irradiation. By week 12, all the p53–/– mice had developed
skin tumors. The experiment was terminated at week 17 after all the
p53–/– mice developed multiple tumors. The percentage of animals
surviving without tumors in UV-exposed p531/1 and p53–/– mice is
shown in Fig 1. A total of 16 tumors developed in six p53–/– mice;
the majority of these tumors being developed on the ears. None of
the UV-irradiated p531/1 mice developed skin tumors by week 17.
The number and site of tumors are summarized in Table I. None of
the control p531/1 and p53–/– mice that were not exposed to UVR
developed skin tumors. Ten tumors were microscopically examined:
five invasive squamous cell carcinomas, four in situ squamous cell
carcinomas, and one actinic keratosis (Table II). Tumor invasion was
defined as malignant-appearing spindle cells peeling off dysplastic
epidermis, as shown in Fig 2.
Effect of UVR on the life-span of p53–/– mice The life expectancy
of p53–/– mice is relatively short due to the development of internal
Table I. Incidence of tumors induced by UV irradiation
p531/1 p53–/– pa
No. of mice 14 12
No. of mice that died before 1 6 0.034
tumor development
No. of tumor bearers 0 6 0.0002
Total no. of tumors 0 16 ,0.0001
Site of tumors:
ear 0 11 ,0.0001
eye 0 4 0.0005
back 0 1 0.003
No. of multiple tumor bearers 0 6 0.0002
Latent period (wk) – 11
aχ2-test.
Table II. Histology and site of UV-induced tumors in p53–/–
mice
Ear Eye Total
Invasive SCC 3 2 5
SCC in situ 3 1 4
Actinic keratosis 1 0 1
Figure 2. Photomicrograph of invasive squamous cell carcinoma arising
from corneal epithelium. Malignant appearing spindle cells, arising from
dysplastic epithelium, are infiltrating the underlying stroma. Scale bar, 100 µm.
tumors or possibly a defective immune system (Donehower et al,
1992). To investigate if UV irradiation had any effect on the life-span
of p53–/– mice, the date of birth and death of each mouse was recorded
in UV-irradiated and control groups. The life expectancy of p53–/– mice
between UV-irradiated and non-UV-irradiated groups was compared
(Fig 3). Statistical analysis indicates that there is no significant difference
in the life expectancy of UV-irradiated mice (20.7 6 4.3 wk, n 5 9)
and that of non-UV-irradiated controls (24.1 6 5.7 wk, n 5 8) (p 5
0.18, Student’s t test).
DISCUSSION
The main objective of this project is to further study the tumor
suppressive effect of p53 in skin cancer development after exposure to
UVR. Because this transgenic model does not contain mutant p53
that may have additional functions (Harvey et al, 1995), we have
elected to use p53-deficient mice as an in vivo model so we can truly
evaluate the role of p53 in UV-induced skin carcinogenesis. Our results
demonstrate that p53–/– mice develop skin cancers with a very short
latent period (Fig 1). At a dose of 2 J per m2 per s of UV irradiation
for 30 min three times per week, all the p53–/– mice developed skin
cancers by week 12, whereas none of the control mice developed skin
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Figure 3. Effect of UVR on life expectancy of p53–/– mice. The life-span
of p53–/– mice was compared between the UV-irradiated group (n 5 12) and
the control group (n 5 12). → indicates the start of UV exposure.
Table III. Comparison of UV carcinogenesis in transgenic
mice carrying mutant p53 alleles and p53-deficient mice
Mutant p53 micea p53-deficient miceb
Genetic background CD-1 C57BL/6
Life-span (mo) 12–24 2–14 (6 on average)
UV carcinogenesisc
UV regimen (kJ per m2 per wk) 24.3 10.8
Latent period (wk) 26 11
Incidence of tumors 19/19 6/6
Multiple tumor bearers 9/19 6/6
2 major sites ear ear
eye eye
DNA repair reducedd reducede
Apoptosis unchangedd reducedf
aLaviguer et al (1989).
bDonehower et al (1992).
cData on mutant p53 mice were from Li et al (1995).
dLi et al (1996).
eLi et al (1997).
fZiegler et al (1994).
cancer by week 17. Kripke et al (1977) reported that C57BL/6 mice
developed skin tumors with a much longer latent period after exposure
to UVR. After exposure to 2.8 J per m2 per s of UV radiation for
30 min three times a week, the minimal time for the first tumor
induction in C57BL/6 mice ranged from 21 to 37 weeks. Therefore,
knockout of the p53 function significantly reduced the latent period
of UV-induced skin cancer development. This provides evidence that
knockout of wild-type p53 function is causal rather than coincidental
in the development of nonmelanoma skin cancers.
Our finding that the majority of the skin tumors occurred on the
ears is in agreement with previous photocarcinogenesis studies by us
and others (Kripke et al, 1975; Li et al, 1995). The reason for the
majority of skin tumors being on the ears is not completely understood.
It may be due to the fact that there is no hair on the ear, so the ears
are less protected from UV irradiation. The hair stubble on the dorsal
area, even with shaving before UV irradiation, may partially block
UVR and protect the dorsal skin from developing tumors.
We have previously shown that p53 transgenic mice that carry both
wild-type and mutant p53 gene developed more skin tumors but with
a similar latent period compared with control mice (Li et al, 1995). A
comparison of UV carcinogenesis in mutant p53 mice and p53-
deficient mice is summarized in Table III. The most striking difference
between these two models is the shortened latent period in p53-
deficient mice. The shortened latent period for skin cancer development
in p53–/– mice suggests that complete loss of wild-type p53 is required
in order to initiate tumorigenesis post-UVR; however, in mutant p53
transgenic mice, once initiation occurs, the mutant p53 protein may
promote the tumorigenesis process, thus resulting in a higher incidence
of skin tumors.
It appears that p53 plays different roles in the development of UV-
induced and chemical-induced skin cancers. We observed a higher
incidence and a shortened latent period of UV-induced skin tumors
in p53-deficient mice, although the tumor incidence of chemical-
induced skin tumors was similar in wild-type and heterozygous p53-
deficient mice and decreased in p53 null mice (Kemp et al, 1993). The
latency of chemical-induced tumors was also similar in wild-type,
heterozygous, and homozygous p53-deficient mice (Kemp et al, 1993);
however, the chemical-induced skin tumors in p53-deficient mice
were more malignant, and the loss of p53 alleles enhanced the rate of
malignant progression (Kemp et al, 1993). It is likely that loss of p53
function is an important step in the initiation of UV-induced skin
cancers, but is only involved in the progression of chemical-induced
skin cancers.
How does wild-type p53 suppress the development of UV-induced
skin cancer? Studies on the biochemical functions of p53 indicate that
p53 regulates cell cycle arrest, nucleotide excision repair, and apoptosis
after UV irradiation. Wild-type p53 acts as a G1-S checkpoint control
(Kastan et al, 1992). After a DNA damage event, such as UV and
ionizing radiation, the p53 protein is elevated (Kastan et al, 1991;
Hall et al, 1993; Yamaizumi and Sugano, 1994). The elevated p53
transcriptionally upregulates p21cip1, a potent inhibitor of cyclin-
dependent kinase (El-Deiry et al, 1993; Harper et al, 1993; Xiong et al,
1993), which in turn induces G1 arrest. It is assumed that G1 arrest
induced by p53 will provide extra time for the cell to repair DNA
damage before the damage is propagated during S phase.
Recent studies also implicate that p53 directly participate in DNA
repair. UVR causes cyclobutane pyrimidine dimers and (6–4)
photoproducts in the DNA. These two photoproducts are repaired
primarily in a process known as nucleotide excision repair. Using CAT
assay and radioimmunoassay, we have demonstrated that the removal
of the cyclobutane pyrimidine dimers and (6–4) photoproducts is
slower in the skin of p53 transgenic mice that carry mutant p53 alleles
(Li et al, 1996) and in p53-deficient mice (Li et al, 1997). If the critical
cell growth regulatory genes are damaged by UVR and not repaired
timely, these DNA damages will lead to cell transformation cancer
development.
Another pathway in which p53 exerts its tumor suppressor function
is in inducing apoptosis. Apoptosis is a self-protective mechanism by
which cells possessing significant DNA damage can be deleted. p53
has been shown to play an important role in apoptosis induced by
many different types of DNA-damaging events, such as UVR (Caelles
et al, 1994; Ziegler et al, 1994), ionizing radiation (Clarke et al, 1993;
Lowe et al, 1993a, b), anti-cancer drugs (Lotem and Sachs, 1993), or
growth factor deprivation (Gottlieb et al, 1994; Zhu et al, 1994). The
role of p53 in UV-induced apoptosis of keratinocytes was demonstrated
by Ziegler et al (1994) that the apoptosis rate was significantly lower
in p53–/– mice than in p531/1 mice in vivo. Similar apoptosis rates
between mutant p53 mice and control mice (Li et al, 1996) may
account for the similar latent period of UV-induced skin tumors in
mutant p53 transgenic mice and control mice (Li et al, 1995).
Because wild-type p53 is required in both DNA repair and apoptosis
after a UV irradiation event, loss of wild-type p53 function will lead
to accumulation of mutations and skin cancer development.
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